MYGN
Myriad Genetics, Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.66
-0.19 ▼ -3.92%
🌙 3월 13일 7:54 PM ET (한국 3/14 08:54)
$4.65
-0.01 ▼ -0.22%
| Index | RUT | P/E | - | EPS (ttm) | -3.95 | Insider Own | 4.87% | Shs Outstand | 0.09B | Perf Week | -9.51% |
| Market Cap | 0.44B | Forward P/E | 32.14 | EPS next Y | 210.03% | Insider Trans | 3.28% | Shs Float | 0.09B | Perf Month | -3.92% |
| Enterprise Value | 0.50B | PEG | 0.55 | EPS next Q | -0.07 | Inst Own | 102.17% | Short Float | 13.07% | Perf Quarter | -35.55% |
| Income | -0.37B | P/S | 0.53 | EPS this Y | -22.05% | Inst Trans | 2.44% | Short Ratio | 9.08 | Perf Half Y | -39.32% |
| Sales | 0.82B | P/B | 1.18 | EPS next 5Y | 58.95% | ROA | -42.2% | Short Interest | 11.63M | Perf YTD | -24.23% |
| Book/sh | 3.94 | P/C | 2.91 | EPS past 3/5Y | -41.67% -8.03% | ROE | -68.45% | 52W High | -55.49% ($10.47) | Perf Year | -51.96% |
| Cash/sh | 1.6 | P/FCF | - | Sales past 3/5Y | 6.72% 5.24% | ROIC | -64.09% | 52W Low | 23.94% ($3.76) | Perf 3Y | -78.5% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -181.57% | Gross Margin | 67.05% | Volatility(W/M) | 7.84% 8.48% | Perf 5Y | -84.99% |
| Dividend TTM | - | EV/Sales | 0.6 | Sales Y/Y TTM | -1.56% | Oper. Margin | -8.22% | ATR (14) | 0.38 | Perf 10Y | -87.55% |
| Dividend Ex-Date | - | Quick Ratio | 2.26 | EPS Q/Q | 81.84% | Profit Margin | -44.38% | RSI (14) | 41.38 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.49 | Sales Q/Q | -0.38% | SMA20 | -2.36% ($4.77) | Beta | 1.87 | Target Price | $7.39 |
| Payout | - | Debt/Eq | 0.57 | Earnings | 2000000 | SMA50 | -13.36% ($5.38) | Rel Volume | 1.35 | Prev Close | $4.85 |
| Employees | 2700 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 368.46% 1.14% | SMA200 | -23.65% ($6.1) | Avg Volume(3M) | 1.28M | Price | $4.66 |
| IPO | 1995/10/6 | Option/Short | Yes/Yes | Trades | 10806 | Volume | 1,723,835 | Change | -3.92% |
뉴스 로딩 중...